S. Innis, Essential fatty acid requirements in human nutrition, Canadian Journal of Physiology and Pharmacology, vol.71, issue.9, pp.699-706, 1993.
DOI : 10.1139/y93-104

J. Steczko and B. Axelrod, Identification of the iron-binding histidine residues in soybean lipoxygenase L-1, Biochemical and Biophysical Research Communications, vol.186, issue.2, pp.31-686, 1992.
DOI : 10.1016/0006-291X(92)90801-Q

M. Hamberg, Steric analysis of hydroperoxides formed by lipoxygenase oxygenation of linoleic acid, Analytical Biochemistry, vol.43, issue.2, pp.515-526, 1971.
DOI : 10.1016/0003-2697(71)90282-X

S. Yamamoto, Mammalian lipoxygenases: molecular structures and functions, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1128, issue.2-3, pp.117-131, 1992.
DOI : 10.1016/0005-2760(92)90297-9

H. Kühn, T. Schewe, and S. Rapoport, The Stereochemistry of the Reactions of Lipoxygenases and Their Metabolites. Proposed Nomenclature of Lipoxygenases and Related Enzymes, Adv Enzymol Relat Areas Mol Biol. Review, vol.74, pp.273-311, 1986.
DOI : 10.1002/9780470123041.ch7

R. Maas, A. Brash, and J. Oates, A second pathway of leukotriene biosynthesis in porcine leukocytes., Proceedings of the National Academy of Sciences, vol.78, issue.9, pp.5523-5527, 1981.
DOI : 10.1073/pnas.78.9.5523

P. Borgeat, B. Fruteau-de-laclos, S. Picard, J. Drapeau, P. Vallerand et al., Studies on the mechanism of formation of the 5SZ)-icosatetraenoic acid in leukocytes, Prostaglandins, vol.126810, issue.23, pp.14-713, 1982.

P. Borgeat and B. Samuelsson, Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid, J Biol Chem, vol.254, pp.2643-2646, 1979.

R. Uauy, E. Birch, D. Birch, and P. Peirano, Visual and brain function measurements in studies of n-3 fatty acid requirements of infants, The Journal of Pediatrics, vol.120, issue.4, pp.168-180, 1992.
DOI : 10.1016/S0022-3476(05)81252-1

L. Horrocks and Y. Yeo, HEALTH BENEFITS OF DOCOSAHEXAENOIC ACID (DHA), Pharmacological Research, vol.40, issue.3, pp.211-225, 1999.
DOI : 10.1006/phrs.1999.0495

M. Croset, M. Guichardant, and M. Lagarde, Different metabolic behavior of long-chain n???3 polyunsaturated fatty acids in human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.961, issue.2, pp.262-269, 1988.
DOI : 10.1016/0005-2760(88)90121-X

P. Sapieha, A. Stahl, J. Chen, M. Seaward, K. Willett et al., 5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ??-3 Polyunsaturated Fatty Acids, Science Translational Medicine, vol.3, issue.69, pp.69-81, 2011.
DOI : 10.1126/scitranslmed.3001571

T. Lee, J. Mencia-huerta, C. Shih, E. Corey, R. Lewis et al., Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils., Journal of Clinical Investigation, vol.74, issue.6, pp.74-1922, 1984.
DOI : 10.1172/JCI111612

M. Aveldaño and H. Sprecher, Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1- 14C] docosahexaenoic acid by human platelets, J Biol Chem, pp.258-9339, 1983.

A. González-périz, A. Planagumà, K. Gronert, R. Miquel, M. López-parra et al., Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators, pp.1-17

P. Chen, B. Fenet, S. Michaud, N. Tomczyk, E. Véricel et al., Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation, FEBS Letters, vol.94, issue.21, pp.3478-3484, 2009.
DOI : 10.1016/j.febslet.2009.10.004

URL : https://hal.archives-ouvertes.fr/inserm-00429322

N. Bazan, J. Calandria, and C. Serhan, Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1, The Journal of Lipid Research, vol.51, issue.8, pp.2018-2031, 2010.
DOI : 10.1194/jlr.R001131

L. Balas, M. Guichardant, T. Durand, and M. Lagarde, Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date, Biochimie, vol.99, pp.99-100, 2014.
DOI : 10.1016/j.biochi.2013.11.006

URL : https://hal.archives-ouvertes.fr/hal-00952184

P. Chen, E. Véricel, M. Lagarde, and M. Guichardant, Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.382-388, 2011.
DOI : 10.1096/fj.10-161836

URL : https://hal.archives-ouvertes.fr/inserm-00517396

M. Liu, T. Boussetta, K. Makni-maalej, M. Fay, F. Driss et al., Protectin DX, a Double Lipoxygenase Product of DHA, Inhibits Both ROS Production in Human Neutrophils and Cyclooxygenase Activities, Lipids, vol.48, issue.1, pp.49-49, 2014.
DOI : 10.1007/s11745-013-3863-6

URL : https://hal.archives-ouvertes.fr/inserm-00909219

M. Croset and M. Lagarde, Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids, Biochemical and Biophysical Research Communications, vol.112, issue.3, pp.878-883, 1983.
DOI : 10.1016/0006-291X(83)91699-6

M. Dona, G. Fredman, J. Schwab, N. Chiang, M. Arita et al., Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets, Blood, vol.112, issue.3, pp.848-855, 2008.
DOI : 10.1182/blood-2007-11-122598

P. White, P. St-pierre, A. Charbonneau, P. Mitchell, E. St-amand et al., Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis, Nature Medicine, vol.263, issue.6, pp.664-669, 2014.
DOI : 10.1038/nprot.2008.73

M. Morita, K. Kuba, A. Ichikawa, M. Nakayama, J. Katahira et al., The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza, Cell, vol.153, issue.1, pp.112-125, 2013.
DOI : 10.1016/j.cell.2013.02.027

D. Mozaffarian and J. Wu, Omega-3 Fatty Acids and Cardiovascular Disease, Journal of the American College of Cardiology, vol.58, issue.20, pp.58-2047, 2011.
DOI : 10.1016/j.jacc.2011.06.063

G. Burdge and S. Wootton, Conversion of ??-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women, British Journal of Nutrition, vol.13, issue.04, pp.411-420, 2002.
DOI : 10.1038/sj.ejcn.1600390

G. Burdge, ??-Linolenic acid metabolism in men and women: nutritional and biological implications, Current Opinion in Clinical Nutrition and Metabolic Care, vol.7, issue.2, pp.137-144, 2004.
DOI : 10.1097/00075197-200403000-00006

D. Sok and M. Kim, Enzymatic formation of 9,16-dihydro(pero)xyoctadecatrienoic acid isomers from alpha-linolenic acid, Arch Biochem Biophys, pp.277-86, 1990.

D. Sok and M. Kim, Conversion of .alpha.-linolenic acid to dihydro(pero)xyoctadecatrienoic acid isomers by soybean and potato lipoxygenases., Journal of Agricultural and Food Chemistry, vol.42, issue.12, pp.2703-2708, 1994.
DOI : 10.1021/jf00048a011

M. Liu, P. Chen, E. Véricel, M. Lelli, L. Béguin et al., Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA, The Journal of Lipid Research, vol.54, issue.8, pp.2083-2094, 2013.
DOI : 10.1194/jlr.M035139

URL : https://hal.archives-ouvertes.fr/inserm-00832286

C. Schneider and A. Brash, Stereospecificity of Hydrogen Abstraction in the Conversion of Arachidonic Acid to 15R-HETE by Aspirin-treated Cyclooxygenase-2. IMPLICATIONS FOR THE ALIGNMENT OF SUBSTRATE IN THE ACTIVE SITE, Journal of Biological Chemistry, vol.275, issue.7, pp.275-4743, 2000.
DOI : 10.1074/jbc.275.7.4743

R. Grée, Further studies on the anti-thromboxane A2 activity of monohydroxylated fatty acids, Biochem Pharmacol, vol.38, pp.1863-1864, 1989.

M. Croset, A. Sala, G. Folco, and M. Lagarde, Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle, Biochemical Pharmacology, vol.37, issue.7, pp.1275-1280, 1988.
DOI : 10.1016/0006-2952(88)90782-4